Dagmar Prasa

Title: Dagmar Prasa: Innovator in Fibrinolysis Detection

Introduction

Dagmar Prasa is a notable inventor based in Erfurt, Germany. She has made significant contributions to the field of biochemistry, particularly in the detection of fibrinolysis inhibiting enzymes. Her innovative work has led to the development of a patented substrate that enhances the detection process.

Latest Patents

Dagmar Prasa holds a patent for her invention titled "Substrates for TAFI (A)." This invention relates to compounds of general formula (I) and acid addition salts thereof. The patent describes the production and use of these compounds as substrates for the detection of TAFIa, a fibrinolysis inhibiting enzyme. The detection process utilizes the absorption between 400 and 412 nm, which results from the formation of 3-carboxy-4-nitrothiophenol from Ellman's reagent over time. This innovative approach has the potential to improve diagnostic methods in medical applications.

Career Highlights

Dagmar Prasa is associated with Dsm IP Assets B.V., where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and excellence in the field of biochemistry.

Collaborations

She collaborates with esteemed colleagues, including Hugo Ziegler and Jörg Stürzebecher, who contribute to her research endeavors. Their combined expertise enhances the quality and impact of their work in the scientific community.

Conclusion

Dagmar Prasa's contributions to the detection of fibrinolysis inhibiting enzymes exemplify her innovative spirit and dedication to advancing biochemistry. Her patented work not only showcases her talent as an inventor but also holds promise for future medical applications.